Worldwide Dissemination of the NDM-Type Carbapenemases in Gram-Negative Bacteria

Abstract EN

The emergence of one of the most recently described carbapenemases, namely, the New Delhi metallo-lactamase (NDM-1), constitutes a critical and growingly important medical issue.

This resistance trait compromises the efficacy of almost all lactams (except aztreonam), including the last resort carbapenems.

Therapeutical options may remain limited mostly to colistin, tigecycline, and fosfomycin.

The main known reservoir of NDM producers is the Indian subcontinent whereas a secondary reservoir seems to have established the Balkans regions and the Middle East.

Although the spread of blaNDM-like genes (several variants) is derived mostly by conjugative plasmids in Enterobacteriaceae, this carbapenemase has also been identified in P.

aeruginosa and Acinetobacter spp.

Acinetobacter sp.

may play a pivotal role for spreading blaNDM genes for its natural reservoir to Enterobacteriaceae.

Rapid diagnostic techniques (Carba NP test) and screening of carriers are the cornerstone to try to contain this outbreak which threatens the efficacy of the modern medicine.